Aya Yaseen Mahmood Alabdali, Sasikala Chinnappan, Basma M. Abd Razik, Mogana R, Shaik Ibrahim Khalivulla, Rahman H
Aya Yaseen Mahmood Alabdali1, Sasikala Chinnappan2*, Basma M. Abd Razik3, Mogana R4, Shaik Ibrahim Khalivulla5, Rahman H6
1The University of Mashreq, Collage of Pharmacy, Iraq, Baghdad.
2,4,5Faculty of Pharmaceutical Sciences, UCSI University Kuala Lumpur (South Wing), No.1, Jalan Menara Gading, UCSI Heights 56000 Cheras, Kuala Lumpur, Malaysia.
3Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, 10001, Baghdad, Iraq.
Volume - 15,
Issue - 6,
Year - 2022
In the past few years, multiple drugs have been produced from traditional raw materials and recent pandemic disease COVID-19 once again research on this matter is being conducted to determine potential therapeutic purposes of different Ayurvedic Indian medicines and herbs. One such medicinal herb is Curcuma longa. Curcumin is strong antioxidant, anti-inflammatory, antispasmodic, antiangiogenic, anti-carcinogenic, as shown by multiple in vitro and in vivo studies. The action of the growth factor receptors is inhibited by curcumin. The anti-inflammatory effect of curcumin is obtained on the cytokines, proteolytic enzymes, eicosanoids, and lipid mediators. The superoxide radicals, nitric oxide and hydrogen peroxide, are sifted by curcumin, while lipid peroxidation is inhibited. Such properties of the compound thus form the foundation for its various therapeutic and pharmacological effects could also hold antiviral properties including COVID-19. The aim of this research is to summarize the updated pharmacological activities of curcumin.
Cite this article:
Aya Yaseen Mahmood Alabdali, Sasikala Chinnappan, Basma M. Abd Razik, Mogana R, Shaik Ibrahim Khalivulla, Rahman H. Pharmacological activities of Curcumin: An update. Research Journal of Pharmacy and Technology. 2022; 15(6):2809-3. doi: 10.52711/0974-360X.2022.00469
Aya Yaseen Mahmood Alabdali, Sasikala Chinnappan, Basma M. Abd Razik, Mogana R, Shaik Ibrahim Khalivulla, Rahman H. Pharmacological activities of Curcumin: An update. Research Journal of Pharmacy and Technology. 2022; 15(6):2809-3. doi: 10.52711/0974-360X.2022.00469 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-6-73
1. Fu Y, Gao R, Cao Y, Guo M, Wei Z, Zhou E, et al. Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-κB signaling pathway in lipopolysaccharide-induced mastitis in mice. International immunopharmacology. 2014;20(1):54-8.
2. Sun X, Liu Y, Li C, Wang X, Zhu R, Liu C, et al. Recent advances of curcumin in the prevention and treatment of renal fibrosis. BioMed research international. 2017;2017.
3. Basnet P, Skalko-Basnet N. Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment. Molecules. 2011;16(6):4567-98.
4. Giordano A, Tommonaro G. Curcumin and cancer. Nutrients. 2019;11(10):2376.
5. Zhang W, Li Q, Yang C, Yang H, Rao J, Zhang X. Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPARγ expression. Biochemical and Biophysical Research Communications. 2020;524(1):70-6.
6. Dai C, Zhang X, Zhang K. New Discovery of Curcumin Combination Therapy and Action Mechanism. Hindawi; 2020.
7. Shakeri A, Ward N, Panahi Y, Sahebkar A. Anti-angiogenic activity of curcumin in cancer therapy: a narrative review. Current vascular pharmacology. 2019;17(3):262-9.
8. Ming J, Ye J, Zhang Y, Xu Q, Yang X, Shao X, et al. Optimal dietary curcumin improved growth performance, and modulated innate immunity, antioxidant capacity and related genes expression of NF-κB and Nrf2 signaling pathways in grass carp (Ctenopharyngodon idella) after infection with Aeromonas hydrophila. Fish & Shellfish Immunology. 2020;97:540-53.
9. Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. Journal of Biological Chemistry. 2005;280(10):9409-15.
10. Kwiecien S, Magierowski M, Majka J, Ptak-Belowska A, Wojcik D, Sliwowski Z, et al. Curcumin: a potent protectant against esophageal and gastric disorders. International journal of molecular sciences. 2019;20(6):1477.
11. Nabavi SF, Daglia M, Moghaddam AH, Habtemariam S, Nabavi SM. Curcumin and Liver Disease: from Chemistry to Medicine. Comprehensive Reviews in Food Science and Food Safety. 2014;13(1):62-77.
12. Panahi Y, Kianpour P, Mohtashami R, Soflaei SS, Sahebkar A. Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study. Journal of Asian natural products research. 2019;21(8):798-805.
13. Saberi-Karimian M, Keshvari M, Ghayour-Mobarhan M, Salehizadeh L, Rahmani S, Behnam B, et al. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complementary Therapies in Medicine. 2020;49:102322.
14. Zhao X-A, Chen G, Liu Y, Chen Y, Wu H, Xiong Y, et al. Curcumin reduces Ly6Chi monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion. Biomedicine & Pharmacotherapy. 2018;106:868-78.
15. Tu C-t, Yao Q-y, Xu B-l, Wang J-y, Zhou C-h, Zhang S-c. Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression. Food and chemical toxicology. 2012;50(9):3343-51.
16. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiological reviews. 2008;88(1):125-72.
17. White CM, Lee J-Y. The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials. Pharmacy Practice (Granada). 2019;17(1).
18. Mirhafez SR, Rezai A, Dehabeh M, Gh BFNM, Bidkhori M, Sahebkar A, et al. Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease. International Journal for Vitamin and Nutrition Research. 2019.
19. Hepatoprotective Effects of Curcumin Nanomicells in Alcohol-induced Liver Injury: Comparison with Curcumin and Silymarin in Mice Model. jmpir. 2020;4(72):64-77.
20. Sreepriya M, Bali G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia. 2005;76(6):549-55.
21. Cao H, Wang Y, He X, Zhang Z, Yin Q, Chen Y, et al. Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma. Mol Pharm. 2015;12(3):922-31.
22. Baum L, Ng AJJoAsd. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. 2004;6(4):367-77.
23. García-Niño WR, Pedraza-Chaverrí J. Protective effect of curcumin against heavy metals-induced liver damage. Food and Chemical Toxicology. 2014;69:182-201.
24. Barchitta M, Maugeri A, Favara G, Magnano San Lio R, Evola G, Agodi A, et al. Nutrition and wound healing: An overview focusing on the beneficial effects of curcumin. International journal of molecular sciences. 2019;20(5):1119.
25. Kant V, Gopal A, Pathak NN, Kumar P, Tandan SK, Kumar D. Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats. International immunopharmacology. 2014;20(2):322-30.
26. Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair and Regeneration. 1999;7(5):362-74.
27. Mani H, Sidhu GS, Kumari R, Gaddipati JP, Seth P, Maheshwari RK. Curcumin differentially regulates TGF-β1, its receptors and nitric oxide synthase during impaired wound healing. Biofactors. 2002;16(1, 2):29-43.
28. Shinzato T, Sato R, Suzuki K, Tomioka S, Sogawa H, Shulga S, et al. Proposal of therapeutic curcumin derivatives for Alzheimer’s disease based on ab initio molecular simulations. Chemical Physics Letters. 2020;738:136883.
29. Gong J, Sun D. Study on the mechanism of curcumin to reduce the inflammatory response of temporal lobe in Alzheimer's disease by regulating miR-146a. Minerva Med. 2020.
30. Reddy VP, Aryal P, Robinson S, Rafiu R, Obrenovich M, Perry G. Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis. Microorganisms. 2020;8(2):199.
31. Wang X, Wang X, Guo Z. Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease. Coordination Chemistry Reviews. 2018;362:72-84.
32. Banerjee R. Effect of curcumin on the metal ion induced fibrillization of amyloid-β peptide. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2014;117:798-800.
33. Picciano AL, Vaden TD. Complexation between Cu(II) and curcumin in the presence of two different segments of amyloid β. Biophysical Chemistry. 2013;184:62-7.
34. Chen S-Y, Chen Y, Li Y-P, Chen S-H, Tan J-H, Ou T-M, et al. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry. 2011;19(18):5596-604.
35. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Statpearls [internet]: StatPearls Publishing; 2020.
36. Pandey P, Rane JS, Chatterjee A, Kumar A, Khan R, Prakash A, et al. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. 2020:1-11.
37. Al-Tawfiq JAJTm, disease i. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). 2020.
38. Ren J-l, Zhang A-H, Wang X-JJPr. Traditional Chinese medicine for COVID-19 treatment. 2020;155:104743.
39. Roy A, Sarkar B, Celik C, Ghosh A, Basu U, Jana M, et al. Can concomitant use of zinc and curcumin with other immunity-boosting nutraceuticals be the arsenal against COVID-19? 2020.
40. Sordillo PP, Helson LJiv. Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections. 2015;29(1):1-4.